ISRG vs. EW, SYK, AMGN, SNY, ELV, PFE, MDT, BMY, VRTX, and REGN
Should you be buying Intuitive Surgical stock or one of its competitors? The main competitors of Intuitive Surgical include Edwards Lifesciences (EW), Stryker (SYK), Amgen (AMGN), Sanofi (SNY), Elevance Health (ELV), Pfizer (PFE), Medtronic (MDT), Bristol-Myers Squibb (BMY), Vertex Pharmaceuticals (VRTX), and Regeneron Pharmaceuticals (REGN). These companies are all part of the "medical" sector.
Edwards Lifesciences (NYSE:EW) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, community ranking, earnings and institutional ownership.
Edwards Lifesciences received 292 more outperform votes than Intuitive Surgical when rated by MarketBeat users. Likewise, 71.93% of users gave Edwards Lifesciences an outperform vote while only 68.99% of users gave Intuitive Surgical an outperform vote.
Edwards Lifesciences currently has a consensus price target of $88.00, suggesting a potential downside of 5.23%. Intuitive Surgical has a consensus price target of $371.60, suggesting a potential downside of 5.35%. Given Intuitive Surgical's higher probable upside, equities analysts plainly believe Edwards Lifesciences is more favorable than Intuitive Surgical.
Edwards Lifesciences has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.36, indicating that its share price is 36% more volatile than the S&P 500.
79.3% of Edwards Lifesciences shares are owned by institutional investors. Comparatively, 82.9% of Intuitive Surgical shares are owned by institutional investors. 1.3% of Edwards Lifesciences shares are owned by insiders. Comparatively, 0.9% of Intuitive Surgical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Intuitive Surgical has higher revenue and earnings than Edwards Lifesciences. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
Intuitive Surgical has a net margin of 25.24% compared to Intuitive Surgical's net margin of 23.35%. Intuitive Surgical's return on equity of 23.56% beat Edwards Lifesciences' return on equity.
In the previous week, Intuitive Surgical had 10 more articles in the media than Edwards Lifesciences. MarketBeat recorded 34 mentions for Intuitive Surgical and 24 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 0.87 beat Intuitive Surgical's score of 0.86 indicating that Intuitive Surgical is being referred to more favorably in the news media.
Summary
Intuitive Surgical beats Edwards Lifesciences on 12 of the 18 factors compared between the two stocks.
Get Intuitive Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ISRG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ISRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Intuitive Surgical Competitors List
Related Companies and Tools